Study of Radiology Manipulator Work Validation by the Radiologist
ConditionSolid Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut Paoli-Calmettes
About this trial
The main objective of this study is to evaluate the pre-filling work on target and non-target lesions, and the detection of any new lesions reported by the MEM trained in protocol evaluations, in a structured table to prepare the radiologist's work in interpreting RECIST 1.1 scans.
To meet this objective, patients taking part in the CIMER study will first have been included in a research protocol requiring scans with RECIST 1.1 interpretation.
The Baseline examination will be performed and interpreted according to RECIST 1.1 without informing the radiologist performing the reading that the patient is included in the study, so as not to introduce an interpretation bias.
During the first evaluation. The investigating MEM alone will carry out a preliminary analysis of the first evaluation and will present his results to the radiologist in charge of the evaluation, who will validate the conformity of the results.
Eligibility criteria
Qualifiers
Male or female aged 18 and over
Patient included in a clinical research protocol in oncology for solid cancer including RECIST 1.1 interpretation
Disease measurable according to RECIST 1.1
Patient not objecting to study participation
Disqualifiers
Patient with renal insufficiency or allergy during the trial no longer allowing injection of iodinated contrast medium
Patient refusing iodinated PDC injection during the study
Patient withdrawn from the study including scanner interpretation in Recist 1.1
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov